Jorge Espinosa

December 16, 2015 | Daily Business Review

Regulations may be on the verge of significant changes, which will reduce the value of off-shore holding companies to U.S. corporations.

By Jorge Espinosa

5 minute read

December 16, 2015 | Daily Business Review

Regulations may be on the verge of significant changes, which will reduce the value of off-shore holding companies to U.S. corporations.

By Jorge Espinosa

5 minute read

December 16, 2014 | Daily Business Review

Few principles in drafting patent licenses are so pervasive as the one established in 'Brulotte,' that royalties cannot extend beyond the expiration of the patent.

By Jorge Espinosa

4 minute read

January 29, 2014 | Daily Business Review

The European Union takes a consolidated approach. Israel requires database registration. Online businesses need to know the laws when they sell abroad.

By Jorge Espinosa

4 minute read

October 11, 2011 | Daily Business Review

Cloud computing creates enormous opportunities to increase efficiency while reducing costs, but it is a complicated minefield of liability that will only show its devastating effects over the coming years.

By Jorge Espinosa

4 minute read

December 12, 2012 | Daily Business Review

Old legal remedies like Florida's "pure" bill of discovery can continue to be relevant in modern practice, writes intellectual property attorney Jorge Espinosa of Espinosa Trueba.

By Jorge Espinosa

4 minute read

May 08, 2013 | Daily Business Review

With Google Glass, a customer looking at a product in a store could see a competitor's price at a competing store flash before his or her eyes, luring away the sale.

By Jorge Espinosa

5 minute read

November 30, 2011 | Daily Business Review

Jorge Espinosa says critics have voiced concerns that the Anti-Counterfeiting Trade Agreement is not consistent with U.S. law and that President Obama does not have the proper authority to bind the U.S. to the agreement without congressional ratification.

By Jorge Espinosa

5 minute read

April 27, 2004 | Law.com

Consumers and manufacturers are locked in a battle over the legitimacy and legality of the so-called parallel market -- the diversion of sales of pharmaceuticals and other products from domestic sources to foreign sources. Given government's historic failure to block consumer access to cheaper products via such markets, the Bush administration would be wise to reconsider its position on the side of manufacturers, says attorney Jorge Espinosa.

By Jorge Espinosa

7 minute read